Indian regulations fail to monitor growing stem-cell use in clinics.
作者信息
Jayaraman K S
出版信息
Nature. 2005 Mar 17;434(7031):259. doi: 10.1038/434259a.
DOI:10.1038/434259a
PMID:15772610
Abstract
摘要
相似文献
1
Indian regulations fail to monitor growing stem-cell use in clinics.
Nature. 2005 Mar 17;434(7031):259. doi: 10.1038/434259a.
2
Stem cell protocols: the NAS guidelines are a useful start.
Hastings Cent Rep. 2005 Nov-Dec;35(6):16-7.
3
Translational research: toward better characterization of human embryonic stem cell lines.
Stem Cells. 2005 Nov-Dec;23(10):1453. doi: 10.1634/stemcells.2005-ed.4.
4
Biologists seek consensus on guidelines for stem-cell research.
Nature. 2004 Oct 21;431(7011):885. doi: 10.1038/431885a.
5
The promise of stem cells.
Nat Neurosci. 2004 Oct;7(10):1013. doi: 10.1038/nn1004-1013.
6
Stem cell politics: the NAS prohibitions pack more bark than bite.
Hastings Cent Rep. 2005 Nov-Dec;35(6):15-6.
7
Patents: patenting of stem cell related inventions in Europe.
Biotechnol J. 2006 Apr;1(4):384-7. doi: 10.1002/biot.200600021.
8
Stem cells: science and society.
Natl Med J India. 2006 Jan-Feb;19(1):47-8.
9
Stem cell research... the road ahead?
Nephrol News Issues. 2006 Apr;20(4):30, 32, 35-6.
10
The paths around stem cell intellectual property.
Nat Biotechnol. 2006 Apr;24(4):411-3. doi: 10.1038/nbt0406-411.
引用本文的文献
1
Stem cell/cellular interventions in human spinal cord injury: Is it time to move from guidelines to regulations and legislations? Literature review and Spinal Cord Society position statement.
Eur Spine J. 2019 Aug;28(8):1837-1845. doi: 10.1007/s00586-019-06003-3. Epub 2019 May 16.
2
Governing stem cell therapy in India: regulatory vacuum or jurisdictional ambiguity?
New Genet Soc. 2014 Oct 2;33(4):413-433. doi: 10.1080/14636778.2014.970269. Epub 2014 Oct 29.
3
Stem cell therapy: hope or hype?
BMJ. 2005 May 21;330(7501):1159-60. doi: 10.1136/bmj.330.7501.1159.
Zotero 插件